Copy Number Variation in Chromosome 1 Candidates
Copy Number Variation in Chromosome 1 Candidates
批准号:
8249121
负责人:
Robert P. Kimberly
金额:
$24.69万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
AffinityAfricanAfrican AmericanAllelesAntigen-Antibody ComplexAsiansAutoimmune DiseasesAutoimmune ProcessB-LymphocytesBiostatistics CoreCaucasiansCaucasoid RaceChromosomes, Human, Pair 1CollaborationsComplexCopy Number PolymorphismDataDevelopmentDisease susceptibilityEnd stage renal failureEquilibriumEuropeanFCGR2A geneFCGR2B geneFCGR2C geneFCGR3A geneFCGR3B geneFamilyFamily memberFc ReceptorFosteringFrequenciesGene TargetingGenesGeneticGenetic Predisposition to DiseaseHispanicsHumanInflammatory Bowel DiseasesInstitutionLaboratoriesLiteratureMalignant NeoplasmsMediatingMusNatureOpsoninPathogenesisPathway interactionsPhenotypePopulationPopulation StudyPredispositionPropertyProteinsPseudogenesReportingResearchRheumatismRiskSeveritiesSeverity of illnessSignal TransductionSystemic Lupus ErythematosusTLR7 geneTimeVariantWorkbasedesigndisease phenotypeethnic minority populationgenetic epidemiologyhealth disparityinsightneutrophilnovelprogramsprotein expressionreceptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Variations in the copy number of a given gene, also known as copy number variation (CNV) or copy number
polymorphisms (CNP), when the frequency exceeds 1%, is a heritable property. CNVs of specific target
genes have been associated with complex phenotypes such as cancer and inflammatory bowel disease.
Indeed, CNV of the target gene, TLR7, has been associated with the autoimmune phenotype in BXSB mice,
and recent data in the human Fc receptor locus suggest that CNV of a neutrophil specific gene in this region
may also be important in autoimmune diseases. We now have data that demonstrate that there are multiple
types of structural variation in the Fc receptor region, both deletions of varying extents and duplications.
Furthermore, since the genes immediately adjacent FCGR3B are pathophysiologically important, we
hypothesize that the full repertoire of activating and inhibitory FcR genes involved in these structural
variations may be most important. In particular, FCGR2C, thought by most to be a pseudogene, encodes a
protein expressed on B cells and provides a counterbalancing signal to the classical concept of the
FCGR2B-mediated "brake" on immune complex driven B cell activity. We hypothesize that the nature and
frequency of these CNVs will be distinct in African Americans, and perhaps Hispanics, compared to
Caucasians and that these differences will contribute to the severity of the disease phenotype over time in
both of these groups. In this Program Project, we have the unique opportunity to define the structural
variations of this genetically and pathophysiologically important region, in ethnic minorities, and to relate this
variation to both disease susceptibility and disease severity over time. Our Specific Aims are 1) To define
the nature of copy number variation in the classical Fc receptor cluster and its relationship to SLE, 2) To
define the relationship between ancestry and the types of copy number variants and 3) To examine other
genes in the "opsonin / immune complex" pathway for copy number variation and relate this variation to
overall SLE risk. Relationship of Project with Overall PPG Priorities. The proposed research plan will
examine the importance of CNV in Fc receptors and other pathway genes. The project will also look at
interactions between genetic ancestry markers and CNV for SLE susceptibility and severity. This research
plan will (1) work with Projects 2 and 3 to identify regional AIMs, (2) draw on the expertise of the Genetic
Epidemiology and Biostatistics Cores in the design and analysis of CNV in relation to regional AIMs,
increase collaboration between partner institutions, (3) foster the continued development of an effective
Rheumatic Diseases Research Program, (4) enhance research efforts toward SLE-related health disparities
and (5) provide novel insight to the genetic etiology of SLE as an autoimmune phenotype that is
disproportionately more frequent and severe among ethnic minority populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
-
批准号:10348654
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10169828
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
-
批准号:10559569
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10265619
-
项目类别:
-
资助金额:$80.71万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
-
批准号:10089400
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
-
批准号:10198426
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Host Factors in Response to Therapeutic Monoclonal Antibodies and Vaccination
-
批准号:10265647
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2020
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10200215
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:9926327
-
项目类别:
-
资助金额:$761.08万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10159992
-
项目类别:
-
资助金额:$875.35万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:9892149
-
项目类别:
-
资助金额:$773.17万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10022791
-
项目类别:
-
资助金额:$98.37万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
Center for Clinical and Translational Science
-
批准号:10436433
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2019
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:9466306
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2015
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:9085533
-
项目类别:
-
资助金额:$713.73万
-
财政年份:2015
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:9128781
-
项目类别:
-
资助金额:$732.37万
-
财政年份:2015
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:9312407
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2015
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:9312408
-
项目类别:
-
资助金额:$14.63万
-
财政年份:2015
-
负责人:Robert P. Kimberly
-
依托单位:
UAB Center for Clinical and Translational Science (CCTS)
-
批准号:8604021
-
项目类别:
-
资助金额:$447.0万
-
财政年份:2014
-
负责人:Robert P. Kimberly
-
依托单位:
A National Consortium to Explore the Genotypic Basis for ESRD in Lupus
-
批准号:7941793
-
项目类别:
-
资助金额:$191.26万
-
财政年份:2009
-
负责人:Robert P. Kimberly
-
依托单位:
海外基金